search panel

Current News

  • Faces of Lung Cancer Report 2016

    Faces of Lung Cancer Report 2016

    Ottawa, ON, November 1, 2016 – The third annual Faces of Lung Cancer Report is released and inspires a message of hope as Lung Cancer Canada charts a path forward to improve the dire situation for Canadian patients. In 2016, multiple sources clearly demonstrated the level of progress that still needs to be made in Canada, specifically when it comes to lung cancer research, rising rates of the disease in women and the consequences of lengthy approval and coverage timelines.

    Read More

  • Stakeholder Briefing

    Stakeholder Briefing

    New Research Shows Canadian Lung Cancer Patients Are Disadvantaged Compared to Their US Peers and Shocking Trends Among Women

    Read More

  • Canadian Cancer Statistics 2016

    Canadian Cancer Statistics 2016

    The Canadian Cancer Society has released the Canadian Cancer Statistics 2016.  Lung cancer remains deadliest cancer for CDN men & women the lowest 5-year survival (17%) of any major cancer.

    Read More

  • Scotiabank Toronto Waterfront Marathon

    Scotiabank Toronto Waterfront Marathon

    Thank you to everyone who participated in the Scotiabank Toronto Waterfront Marathon in support of lung cancer!

    Read More

  • Lung Cancer is not Just a Smoker's Disease!

    Lung Cancer is not Just a Smoker's Disease!

    As a healthy, active non-smoker, Jessica Steinberg was shocked by her diagnosis.  Jessica had to face a life-threatening cancer diagnosis while juggling single parenthood.

    Read More

  • pCODR Recommends Nivolumab (Opdivo)

    pCODR Recommends Nivolumab (Opdivo)

    pCODR recommends nivolumab (Opdivo) for funding in its Final Recommendation for metastatic NSCLC (both squamous and non-squamous); on or after chemotherapy. No test required.

    This is a great news for NSCLC patients! We hope to see more like this for other types of lung cancer.

    Read More

Latest Tweets